Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Colorectal Neoplasms and CES2[original query] |
|---|
| Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene. Cancer chemotherapy and pharmacology 2008 Mar 61 (3): 481-8. Bellott Ricardo, Le Morvan Valérie, Charasson Virginie, Laurand Armelle, Colotte Marthe, Zanger Ulrich M, Klein Kathrin, Smith Denis, Bonnet Jacques, Robert Jacqu |
| Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients. British journal of cancer 2008 Oct 99 (8): 1239-45. Rouits E, Charasson V, Pétain A, Boisdron-Celle M, Delord J-P, Fonck M, Laurand A, Poirier A-L, Morel A, Chatelut E, Robert J, Gamelin |
| A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression. Current drug metabolism 2008 May 9 (4): 336-43. Ribelles N, López-Siles J, Sánchez A, González E, Sánchez M J, Carabantes F, Sánchez-Rovira P, Márquez A, Dueñas R, Sevilla I, Alba |
| A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Apr 17 (7): 2006-13. Caronia Daniela, Martin Miguel, Sastre Javier, de la Torre Julio, García-Sáenz José Angel, Alonso Maria R, Moreno Leticia T, Pita Guillermo, Díaz-Rubio Eduardo, Benítez Javier, González-Neira An |
- Page last reviewed:Feb 1, 2024
- Content source: